The combination of anti-EGFR drugs with radiotherapy and chemotherapy has been widely used in the treatment of a variety of cancers, including nasopharyngeal cancer, colorectal cancer, and non-small cell lung cancer (12–14). Here, EGFR is linked to non-small cell lung carcinoma.